Prostate Cancer
External validation of preoperative nomograms predicting biochemical recurrence after radical prostatectomy - Abstract
November 18, 2013
Regional variation in quality of prostate cancer care - Abstract
November 18, 2013
Psychological impact of prostate biopsy: Physical symptoms, anxiety, and depression - Abstract
November 18, 2013
Robust plan optimization for electromagnetic transponder guided hypo-fractionated prostate treatment using volumetric modulated arc therapy - Abstract
November 18, 2013
Cancer-associated bone disease - Abstract
November 18, 2013
Algeta ASA: Xofigo® (radium Ra 223 dichloride) granted marketing authorization in the European Union
November 15, 2013
Prognostic model predicting metastatic castration-resistant prostate cancer survival in men treated with second-line chemotherapy - Abstract
November 15, 2013
Post-radical prostatectomy predictive factors for biochemical recurrence - Abstract
November 15, 2013
Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer - Abstract
November 15, 2013
Racial differences in longitudinal changes in serum prostate-specific antigen levels: The Olmsted County Study and the Flint Men's Health Study - Abstract
November 15, 2013
An assessment of PTV margin based on actual accumulated dose for prostate cancer radiotherapy - Abstract
November 15, 2013
Evaluation of safety and analgesic consumption in patients with advanced cancer treated with zoledronic acid - Abstract
November 14, 2013
"N of 1" case reports in the era of whole-genome sequencing - Abstract
November 14, 2013